Abstract
Objective: To assess, by the average INR (international normalized ratio), therapeutic equivalence between branded and generic warfarin sodium in patients with atrial fibrillation in Brazil. Methods: crossover randomized controlled clinical trial. It will be used the branded warfarin sodium (Marevan®, União Química/Farmoquímica, referred as R) and both generic formulations (União Química …